Ali Flores‐Pérez

564 total citations
14 papers, 440 citations indexed

About

Ali Flores‐Pérez is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ali Flores‐Pérez has authored 14 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Ali Flores‐Pérez's work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (4 papers) and RNA modifications and cancer (3 papers). Ali Flores‐Pérez is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (4 papers) and RNA modifications and cancer (3 papers). Ali Flores‐Pérez collaborates with scholars based in Mexico, United States and Bangladesh. Ali Flores‐Pérez's co-authors include César López‐Camarillo, Laurence A. Marchat, Erika Ruíz‐García, Horacio Astudillo‐de la Vega, Elena Aréchaga-Ocampo, Miguel A. Fonseca-Sánchez, Carlos Pérez‐Plasencia, José Díaz‐Chávez, Sergio Rodrı́guez-Cuevas and Verónica Bautista‐Piña and has published in prestigious journals such as PLoS ONE, Scientific Reports and Advances in experimental medicine and biology.

In The Last Decade

Ali Flores‐Pérez

14 papers receiving 434 citations

Peers

Ali Flores‐Pérez

ONCOL

PFM

Nianping Chen China

Enrique García‐Villa Mexico

Xiao Zhou China

Serina King United States

Dang Ma China

Lilia Turcios United States

Amit Dipak Amin United States

Xinshu Dong China

Sunitha Siriwardana United States

Ying-Hong Shi China

Nianping Chen China

Ali Flores‐Pérez

284 ×0.9

96 ×0.5

79 ×0.9

ONCOL

42 ×1.0

PFM

60 ×1.5

Citations per year, relative to Ali Flores‐Pérez Ali Flores‐Pérez (= 1×) peers Nianping Chen

Countries citing papers authored by Ali Flores‐Pérez

Since Specialization

Citations

This map shows the geographic impact of Ali Flores‐Pérez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Flores‐Pérez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Flores‐Pérez more than expected).

Fields of papers citing papers by Ali Flores‐Pérez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Flores‐Pérez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Flores‐Pérez. The network helps show where Ali Flores‐Pérez may publish in the future.

Co-authorship network of co-authors of Ali Flores‐Pérez

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Flores‐Pérez. A scholar is included among the top collaborators of Ali Flores‐Pérez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Flores‐Pérez. Ali Flores‐Pérez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Palma‐Flores, Carlos, Ali Flores‐Pérez, Yarely M. Salinas-Vera, et al.. (2022). MicroRNA-204/CREB5 axis regulates vasculogenic mimicry in breast cancer cells. Cancer Biomarkers. 35(1). 47–56. 12 indexed citations

Flores‐Pérez, Ali, et al.. (2019). Nutrition, Cancer and Personalized Medicine. Advances in experimental medicine and biology. 1168. 157–168. 15 indexed citations

Vega, Horacio Astudillo‐de la, et al.. (2019). Oncobiome at the Forefront of a Novel Molecular Mechanism to Understand the Microbiome and Cancer. Advances in experimental medicine and biology. 1168. 147–156. 6 indexed citations

Flores‐Pérez, Ali, Dolores Gallardo Rincón, Erika Ruíz‐García, et al.. (2017). Angiogenesis Analysis by In Vitro Coculture Assays in Transwell Chambers in Ovarian Cancer. Methods in molecular biology. 1699. 179–186. 16 indexed citations

Pérez‐Plasencia, Carlos, Patricio Gariglio, Laurence A. Marchat, et al.. (2017). DNA methylation data for identification of epigenetic targets of resveratrol in triple negative breast cancer cells. Data in Brief. 11. 169–182. 17 indexed citations

Aréchaga-Ocampo, Elena, César López‐Camarillo, Nicolás Villegas‐Sepúlveda, et al.. (2017). Tumor suppressor miR-29c regulates radioresistance in lung cancer cells. Tumor Biology. 39(3). 3726131101–3726131101. 45 indexed citations

Flores‐Pérez, Ali, Laurence A. Marchat, Sergio Rodrı́guez-Cuevas, et al.. (2016). Dual targeting of ANGPT1 and TGFBR2 genes by miR-204 controls angiogenesis in breast cancer. Scientific Reports. 6(1). 34504–34504. 58 indexed citations

Pérez‐Plasencia, Carlos, Laurence A. Marchat, Patricio Gariglio, et al.. (2016). Methylation Landscape of Human Breast Cancer Cells in Response to Dietary Compound Resveratrol. PLoS ONE. 11(6). e0157866–e0157866. 54 indexed citations

Flores‐Pérez, Ali, Laurence A. Marchat, Sergio Rodrı́guez-Cuevas, et al.. (2016). Suppression of cell migration is promoted by miR-944 through targeting of SIAH1 and PTP4A1 in breast cancer cells. BMC Cancer. 16(1). 379–379. 36 indexed citations

10.

Flores‐Pérez, Ali, Laurence A. Marchat, Elena Aréchaga-Ocampo, et al.. (2015). Differential proteomic analysis reveals that EGCG inhibits HDGF and activates apoptosis to increase the sensitivity of non‐small cells lung cancer to chemotherapy. PROTEOMICS - CLINICAL APPLICATIONS. 10(2). 172–182. 37 indexed citations

11.

Flores‐Pérez, Ali, Elena Aréchaga-Ocampo, Sara Frı́as, et al.. (2014). RAD50 targeting impairs DNA damage response and sensitizes human breast cancer cells to cisplatin therapy. Cancer Biology & Therapy. 15(6). 777–788. 24 indexed citations

12.

Palacios, Yadira, Sergio Rodrı́guez-Cuevas, Verónica Bautista‐Piña, et al.. (2014). Comparative proteomic profiling of triple-negative breast cancer reveals that up-regulation of RhoGDI-2 is associated to the inhibition of caspase 3 and caspase 9. Journal of Proteomics. 111. 198–211. 21 indexed citations

13.

Díaz‐Chávez, José, Miguel A. Fonseca-Sánchez, Elena Aréchaga-Ocampo, et al.. (2013). Proteomic Profiling Reveals That Resveratrol Inhibits HSP27 Expression and Sensitizes Breast Cancer Cells to Doxorubicin Therapy. PLoS ONE. 8(5). e64378–e64378. 59 indexed citations

14.

Fonseca-Sánchez, Miguel A., Carlos Pérez‐Plasencia, Elena Aréchaga-Ocampo, et al.. (2013). microRNA-18b is upregulated in breast cancer and modulates genes involved in cell migration. Oncology Reports. 30(5). 2399–2410. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact